Literature DB >> 23109786

Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation.

Paolo Angelini1, Carlo Uribe, Jorge Monge, Jorge M Escobar, Eduardo Hernandez-Vila.   

Abstract

We report a case of severe apical hypertrophic cardiomyopathy in order to discuss the nature of this unusual condition and the possibility of using selective alcohol ablation to effectively treat symptomatic hypertrophic cardiomyopathy that presents with apical aneurysm. A 73-year-old woman with severe, progressive dyspnea and intermittent chest pain was found to have localized left ventricular apical dyskinesia distal to an obstructive mid-distal muscular ring. The ring caused total systolic obliteration of the apical left ventricular cavity. Apical cavity pressure was extremely high, up to 330 mmHg-200 mmHg above that in the main left ventricular cavity. Because of the danger of apical rupture and clot formation, we attempted the experimental use of alcohol ablation for effective palliation. We present our pilot experience, offer a novel interpretation of the nature of this obscure entity, and possibly justify a new catheter treatment. In addition, we discuss the developmental, pathophysiologic, and clinical implications of this unusual form of hypertrophic cardiomyopathy. To our knowledge, ours is the first reported use of subselective, modified-protocol alcohol septal ablation to treat an obstructive mid-apical muscular ring in a patient with apical hypertrophic cardiomyopathy.

Entities:  

Keywords:  Cardiomyopathy, hypertrophic/complications/epidemiology/physiopathology/therapy; ethanol/administration & dosage/therapeutic use; heart septum/pathology; hypertrophy, left ventricular/diagnosis; myocardial ischemia/complications; treatment outcome

Mesh:

Substances:

Year:  2012        PMID: 23109786      PMCID: PMC3461680     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration.

Authors:  T Nakamura; K Matsubara; K Furukawa; A Azuma; H Sugihara; H Katsume; M Nakagawa
Journal:  J Am Coll Cardiol       Date:  1992-03-01       Impact factor: 24.094

2.  Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  Circulation       Date:  2007-07-10       Impact factor: 29.690

3.  Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; John J Finley; J Martijn Bos; Thomas H Hauser; Warren J Manning; Tammy S Haas; John R Lesser; James E Udelson; Michael J Ackerman; Barry J Maron
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

4.  Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.

Authors:  N M Lakkis; S F Nagueh; N S Kleiman; D Killip; Z X He; M S Verani; R Roberts; W H Spencer
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

Review 5.  Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review.

Authors:  Xiao-Jin Gao; Lian-Ming Kang; Jian Zhang; Ke-Fei Dou; Jian-Song Yuan; Yue-Jin Yang
Journal:  Chin Med J (Engl)       Date:  2011-06       Impact factor: 2.628

6.  Simultaneous pressure recording in mid-ventricular obstructive hypertrophic cardiomyopathy.

Authors:  Yousuke Hanaoka; Ikuo Misumi; Taku Rokutanda; Ryuichiro Akahoshi; Mitsuhiro Matsumoto; Tomohiro Sakamoto; Koichi Kaikita; Megumi Yamamuro; Seigo Sugiyama; Hisao Ogawa
Journal:  Intern Med       Date:  2012-02-15       Impact factor: 1.271

7.  Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Authors:  Martin S Maron; Iacopo Olivotto; Andrey G Zenovich; Mark S Link; Natesa G Pandian; Jeffery T Kuvin; Stefano Nistri; Franco Cecchi; James E Udelson; Barry J Maron
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

8.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

9.  Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation.

Authors:  Yuichi Sato; Naoya Matsumoto; Shinro Matsuo; Shunichi Yoda; Shigemasa Tani; Yuji Kasamaki; Tadateru Takayama; Satoshi Kunimoto; Satoshi Saito
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

Review 10.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007
  10 in total
  4 in total

1.  Should the ECG Be Excluded from Sports Certification Screening? A Typical Case Supports Inclusion.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2015-12-01

2.  Apical hypertrophic cardiomyopathy.

Authors:  Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2012

Review 3.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

4.  Two cases of apical ballooning syndrome masking apical hypertrophic cardiomyopathy.

Authors:  Ranjini Raina Roy; Fayaz A Hakim; R Todd Hurst; David Simper; Christopher P Appleton
Journal:  Tex Heart Inst J       Date:  2014-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.